These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23446780)

  • 1. Diabetes and HIV: current understanding and future perspectives.
    Kalra S; Agrawal N
    Curr Diab Rep; 2013 Jun; 13(3):419-27. PubMed ID: 23446780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and skeletal complications of HIV infection: the price of success.
    Morse CG; Kovacs JA
    JAMA; 2006 Aug; 296(7):844-54. PubMed ID: 16905789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.
    Barbaro G
    Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection.
    Samaras K
    J Antimicrob Chemother; 2008 Feb; 61(2):238-45. PubMed ID: 18070830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and HIV.
    Noubissi EC; Katte JC; Sobngwi E
    Curr Diab Rep; 2018 Oct; 18(11):125. PubMed ID: 30294763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and management of dyslipidemia in patients with HIV infection.
    Green ML
    J Gen Intern Med; 2002 Oct; 17(10):797-810. PubMed ID: 12390557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients.
    Tomazic J; Silic A; Karner P; Vidmar L; Maticic M; Poljak M; Ihan A; Janez A
    Wien Klin Wochenschr; 2004 Nov; 116(21-22):755-9. PubMed ID: 15628647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of inflammation to fat redistribution and metabolic disturbances in HIV-1 infected patients.
    Stankov MV; Behrens GM
    Curr Pharm Des; 2010 Oct; 16(30):3361-71. PubMed ID: 20687889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
    Wierzbicki AS; Purdon SD; Hardman TC; Kulasegaram R; Peters BS
    Curr Med Res Opin; 2008 Mar; 24(3):609-24. PubMed ID: 18208641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.
    Barbaro G
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):337-43. PubMed ID: 16101566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
    Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
    AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the metabolic effects of HIV and HIV drugs.
    Brown TT; Glesby MJ
    Nat Rev Endocrinol; 2011 Sep; 8(1):11-21. PubMed ID: 21931374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of common chronic metabolic complications in HIV-infected patients.
    Bader MS; Kelly DV
    Postgrad Med; 2008 Nov; 120(4):17-27. PubMed ID: 19020362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal glucose metabolism among older men with or at risk of HIV infection.
    Howard AA; Floris-Moore M; Lo Y; Arnsten JH; Fleischer N; Klein RS
    HIV Med; 2006 Sep; 7(6):389-96. PubMed ID: 16903984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?
    Behrens GM; Stoll M; Schmidt RE
    Drug Saf; 2000 Jul; 23(1):57-76. PubMed ID: 10915032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients.
    Florescu D; Kotler DP
    Antivir Ther; 2007; 12(2):149-62. PubMed ID: 17503657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance in the HIV-infected population: the potential role of mitochondrial dysfunction.
    Shikuma CM; Day LJ; Gerschenson M
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):255-62. PubMed ID: 16181144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of diabetes mellitus, hyperinsulinaemia and metabolic syndrome among 755 adult patients with HIV-1 infection.
    Calza L; Masetti G; Piergentili B; Trapani F; Cascavilla A; Manfredi R; Colangeli V; Viale P
    Int J STD AIDS; 2011 Jan; 22(1):43-5. PubMed ID: 21364066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.
    Mandal A; Mukherjee A; Lakshmy R; Kabra SK; Lodha R
    Indian J Pediatr; 2016 Mar; 83(3):226-31. PubMed ID: 26334860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.